Albumin paclitaxel clinical trials
Albumin paclitaxel is named as an intervention in 26 current clinical trials in our China register. 18 are recruiting patients now. The most common phase is Phase 2. The sponsor with the most trials is Henan Cancer Hospital (3). The most-studied condition is Oral Squamous Cell Carcinoma.
Patient leaflets for Albumin paclitaxel
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Albumin paclitaxel
26 trialsRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Albumin paclitaxel
34 conditionsAll 34 conditions
| Condition (as registered) | Trials |
|---|---|
| Oral Squamous Cell Carcinoma | 2 |
| Breast Cancer | 2 |
| Gastric Cancer | 2 |
| Salivary Gland Carcinoma | 1 |
| Precision Therapy | 1 |
| NSCLC (Advanced Non-small Cell Lung Cancer) | 1 |
| Esophageal Cancer | 1 |
| Metastatic Pancreatic Ductal Adenocarcinoma | 1 |
| Advanced and Metastatic NSCLC | 1 |
| Pancreatic Ductal Adenocarcinoma | 1 |
| Hematologic Malignancy | 1 |
| Solid Tumor | 1 |
| Early-Stage Oral Squamous Cell Carcinoma | 1 |
| Paget Disease, Extramammary | 1 |
| Rhabdomyosarcoma | 1 |
| Testicular Cancer | 1 |
| Penile Cancer | 1 |
| HER2-low Breast Cancer | 1 |
| HER2-positive Breast Cancer | 1 |
| Non-small Cell Lung Cancer Metastatic | 1 |
| First-line Treatment | 1 |
| Breast Cancer Early Stage Breast Cancer (Stage 1-3) | 1 |
| Diffuse Type Carcinoma | 1 |
| HR+/HER2- Breast Cancer | 1 |
| Locally Advanced Hypopharyngeal Cancer | 1 |
| Pancreatic Neoplasms | 1 |
| Immunotherapy Esophagus Cancer | 1 |
| Neoadjvant Therapy | 1 |
| Anti-PD-1 | 1 |
| Chemotherapy | 1 |
| Locally Advanced Pancreatic Cancer | 1 |
| Head and Neck Squamous Cell Carcinoma | 1 |
| Triple-negative Breast Cancer | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
Sponsors
lead sponsor per trial+ 6 more sponsors in the trial list above.
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 26 | 18 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Albumin paclitaxel trials
How many clinical trials are testing Albumin paclitaxel?
26 current trials in our China register name Albumin paclitaxel as a drug or biological intervention, as of the registry sync on 8 November 2026. Completed and withdrawn studies are not counted.
Are Albumin paclitaxel trials recruiting patients?
Yes. 18 of the 26 trials are recruiting: 18 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Albumin paclitaxel clinical trials?
Henan Cancer Hospital (3), Chipscreen Biosciences, Ltd (2), Tianjin Medical University Cancer Institute and Hospital (2) and Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2), among 21 lead sponsors in total. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Albumin paclitaxel works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Albumin paclitaxel works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Albumin paclitaxel (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 8 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.